• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对阿什肯纳兹犹太人群进行泰-萨克斯病筛查:国际及澳大利亚的经验。

Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.

作者信息

Lew Raelia M, Burnett Leslie, Proos Anné L, Barlow-Stewart Kristine, Delatycki Martin B, Bankier Agnes, Aizenberg Harry, Field Michael J, Berman Yemima, Fleischer Ronald, Fietz Michael

机构信息

Department of Obstetrics and Gynaecology, QEII Research Institute for Mothers and Infants, University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Paediatr Child Health. 2015 Mar;51(3):271-9. doi: 10.1111/jpc.12632. Epub 2014 Jun 13.

DOI:10.1111/jpc.12632
PMID:24923490
Abstract

Internationally, Tay-Sachs disease (TSD) preconception screening of Ashkenazi Jewish (AJ) individuals and couples has led to effective primary prevention of TSD. In Australia, adolescent preconception genetic screening programs operate mainly in Jewish community high schools. These existing programs offer an effective means of primary prevention of TSD, are cost effective and safe. However, in the broader Australian community TSD screening is not systematically performed and cases still occur in unscreened AJ individuals. In order to improve the effectiveness of Australian screening, there is a need for definitive guidelines for healthcare professionals to facilitate extension of the proven benefits of preconception TSD screening to all AJ individuals at risk. We performed a systematic review of the relevant literature relating to AJ pre-conception and antenatal screening for TSD. The evidence was assessed using an established National Health and Medical Research Council evidence grading system. Evaluations of efficacy of TSD screening programs design and execution, cost-benefit and cost-utility health economic evaluation, and population outcomes were undertaken. The results have been used to propose a model for universal AJ TSD preconception and antenatal screening for the primary care setting.

摘要

在国际上,对阿什肯纳兹犹太(AJ)个体及夫妇进行泰-萨克斯病(TSD)孕前筛查已实现了对TSD的有效一级预防。在澳大利亚,青少年孕前基因筛查项目主要在犹太社区高中开展。这些现有项目提供了一种有效的TSD一级预防手段,具有成本效益且安全。然而,在更广泛的澳大利亚社区,并未系统地开展TSD筛查,未接受筛查的AJ个体中仍有病例出现。为提高澳大利亚筛查的有效性,需要为医疗保健专业人员制定明确的指南,以促进将已证实的孕前TSD筛查益处扩展至所有有风险的AJ个体。我们对与AJ孕前及产前TSD筛查相关的文献进行了系统综述。使用既定的澳大利亚国家卫生与医学研究委员会证据分级系统对证据进行了评估。对TSD筛查项目设计与实施的效果、成本效益和成本效用健康经济评估以及人群结果进行了评价。研究结果已用于提出一个适用于初级保健环境的通用AJ TSD孕前及产前筛查模型。

相似文献

1
Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.对阿什肯纳兹犹太人群进行泰-萨克斯病筛查:国际及澳大利亚的经验。
J Paediatr Child Health. 2015 Mar;51(3):271-9. doi: 10.1111/jpc.12632. Epub 2014 Jun 13.
2
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰萨二氏病的孕前风险评估。
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
3
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2.
5
Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.澳大利亚的泰萨二氏病:尽管澳大利亚犹太人的携带者频率稳定,但疾病发病率降低。
Med J Aust. 2012 Dec 10;197(11):652-4. doi: 10.5694/mja12.11010.
6
Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.泰-萨克斯病——携带者筛查、产前诊断与分子时代。1970年至1993年的国际视角。国际泰-萨克斯病数据收集网络
JAMA. 1993 Nov 17;270(19):2307-15.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
Chemoprevention of colorectal cancer: systematic review and economic evaluation.结直肠癌的化学预防:系统评价和经济评估。
Health Technol Assess. 2010 Jun;14(32):1-206. doi: 10.3310/hta14320.
9
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
10
Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation.Elucigene FH20 和 LIPOchip 用于家族性高胆固醇血症的诊断:系统评价和经济评估。
Health Technol Assess. 2012;16(17):1-266. doi: 10.3310/hta16170.

引用本文的文献

1
Cost-effectiveness of population-based expanded reproductive carrier screening for genetic diseases in Australia: a microsimulation analysis.澳大利亚基于人群的扩大遗传性疾病生殖携带者筛查的成本效益:微观模拟分析
Eur J Hum Genet. 2025 Apr 16. doi: 10.1038/s41431-025-01835-8.
2
Redefining the approach to rare diseases: the experience of "Casa dos Raros" in Brazil.重新定义罕见病治疗方法:巴西“罕见病之家”的经验。
J Community Genet. 2025 Feb 6. doi: 10.1007/s12687-025-00771-w.
3
Community Genetics screening in a pandemic: solutions for pre-test education, informed consent, and specimen collection.
社区遗传学筛查在大流行中的应用:解决检测前教育、知情同意和标本采集问题。
Eur J Hum Genet. 2023 Mar;31(3):257-261. doi: 10.1038/s41431-022-01251-2. Epub 2023 Jan 11.
4
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰萨二氏病的孕前风险评估。
Cochrane Database Syst Rev. 2021 Oct 11;10(10):CD010849. doi: 10.1002/14651858.CD010849.pub4.
5
The Core Outcome DEvelopment for Carrier Screening (CODECS) study: protocol for development of a core outcome set.核心携带者筛查结局发展(CODECS)研究:核心结局集制定的方案。
Trials. 2021 Jul 22;22(1):480. doi: 10.1186/s13063-021-05439-7.
6
Survey on patients' organisations' knowledge and position paper on screening for inherited neuromuscular diseases in Europe.欧洲患者组织对遗传性神经肌肉疾病筛查的认知及立场文件调查。
Orphanet J Rare Dis. 2021 Feb 10;16(1):75. doi: 10.1186/s13023-020-01670-8.
7
Equitable Expanded Carrier Screening Needs Indigenous Clinical and Population Genomic Data.公平扩大携带者筛查需要原住民临床和群体基因组数据。
Am J Hum Genet. 2020 Aug 6;107(2):175-182. doi: 10.1016/j.ajhg.2020.06.005.
8
Consanguinity and genetic diseases among the Bedouin population in the Negev.内盖夫地区贝都因人群中的近亲结婚与遗传疾病
J Community Genet. 2020 Jan;11(1):13-19. doi: 10.1007/s12687-019-00433-8. Epub 2019 Aug 2.
9
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.地中海贫血、镰状细胞病、囊性纤维化和泰-萨克斯病的孕前风险评估。
Cochrane Database Syst Rev. 2018 Mar 14;3(3):CD010849. doi: 10.1002/14651858.CD010849.pub3.
10
Roads to Health in Developing Countries: Understanding the Intersection of Culture and Healing.发展中国家的健康之路:理解文化与治愈的交叉点。
Curr Ther Res Clin Exp. 2017 Mar 4;86:13-18. doi: 10.1016/j.curtheres.2017.03.001. eCollection 2017.